Literature DB >> 28578204

Pericytes and cardiac stem cells: Common features and peculiarities.

Antonio Paolo Beltrami1, Paolo Madeddu2.   

Abstract

Clinical data and basic research indicate that the structural and functional alterations that characterize the evolution of cardiac disease towards heart failure may be, at least in part, reversed. This paradigm shift is due to the accumulation of evidence indicating that, in peculiar settings, cardiomyocytes may be replenished. Moving from the consideration that cardiomyocytes are rapidly withdrawn from the cell cycle after birth, independent laboratories have tested the hypothesis that cardiac resident stem/progenitor cells resided in mammalian hearts and were important for myocardial repair. After almost two decades of intensive investigation, several (but partially overlapping) cardiac resident stem/progenitor cell populations have been identified. These primitive cells are characterized by mesenchymal features, unique properties that distinguish them from mesodermal progenitors residing in other tissues, and heterogeneous embryological origins (that include the neural crest and the epicardium). A further layer of complexity is related to the nature, in vivo localization and properties of mesodermal progenitors residing in adult tissues. Intriguingly, these latter, whose possible perivascular pericyte/mural cell origin has been shown, have been identified in human hearts too. However, their exact anatomical localization, pathophysiological role, and their relationship with cardiac stem/progenitor cells are emerging only recently. Therefore, aim of this review is to discuss the different origin, the distinct nature, and the complementary effect of cardiac stem cells and pericytes supporting regenerative strategies based on the combined use of both myogenic and angiogenic factors.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac stem cells; Cardiomyocyte proliferation; Heart; Heart failure; Pericytes; Proepicardial organ; Sca-1; Side population; Tbx18; cKit

Mesh:

Year:  2017        PMID: 28578204     DOI: 10.1016/j.phrs.2017.05.023

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  7 in total

1.  A Missing LNC in Vascular Diseases.

Authors:  John P Cooke; Nicholas J Leeper
Journal:  Circ Res       Date:  2017-08-04       Impact factor: 17.367

2.  Mapping the cardiac vascular niche in heart failure.

Authors:  Fabian Peisker; Maurice Halder; James Nagai; Susanne Ziegler; Nadine Kaesler; Konrad Hoeft; Ronghui Li; Eric M J Bindels; Christoph Kuppe; Julia Moellmann; Michael Lehrke; Christian Stoppe; Michael T Schaub; Rebekka K Schneider; Ivan Costa; Rafael Kramann
Journal:  Nat Commun       Date:  2022-05-31       Impact factor: 17.694

Review 3.  Heterocellularity and Cellular Cross-Talk in the Cardiovascular System.

Authors:  Filippo Perbellini; Samuel A Watson; Ifigeneia Bardi; Cesare M Terracciano
Journal:  Front Cardiovasc Med       Date:  2018-11-01

Review 4.  Cellular and Molecular Heterogeneity Associated with Vessel Formation Processes.

Authors:  Pollyana Ribeiro Castro; Alan Sales Barbosa; Jousie Michel Pereira; Hedden Ranfley; Mariane Felipetto; Carlos Alberto Xavier Gonçalves; Isabela Ribeiro Paiva; Bárbara Betônico Berg; Luciola Silva Barcelos
Journal:  Biomed Res Int       Date:  2018-10-10       Impact factor: 3.411

Review 5.  Role of Podoplanin-Positive Cells in Cardiac Fibrosis and Angiogenesis After Ischemia.

Authors:  Maria Cimini; Raj Kishore
Journal:  Front Physiol       Date:  2021-04-12       Impact factor: 4.566

Review 6.  Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation.

Authors:  Carolina Balbi; Ambra Costa; Lucio Barile; Sveva Bollini
Journal:  Cells       Date:  2020-03-15       Impact factor: 6.600

Review 7.  Emerging Role of Pericytes and Their Secretome in the Heart.

Authors:  Han Su; Aubrey C Cantrell; Heng Zeng; Shai-Hong Zhu; Jian-Xiong Chen
Journal:  Cells       Date:  2021-03-04       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.